Selecta Biosciences, Inc.
NASDAQ:SELB
0.8812 (USD) • At close November 13, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities: | |||||||||||
Net Income
| -219.71 | 35.379 | -25.687 | -68.876 | -55.35 | -65.336 | -65.321 | -36.21 | -25.174 | -12.88 | -15.177 |
Depreciation & Amortization
| 0.764 | 1.287 | 1.252 | 0.734 | 2.027 | 0.975 | 0.75 | 0.802 | 1.044 | 0.864 | 0.914 |
Deferred Income Tax
| -19 | 0 | 2.396 | 10.852 | 0.806 | -0.182 | 0.942 | 0.208 | -0.083 | 0.038 | 0 |
Stock Based Compensation
| 0 | 11.194 | 7.72 | 5.422 | 5.161 | 5.714 | 4.081 | 2.051 | 1.125 | 1.224 | 0.775 |
Change In Working Capital
| 3.56 | -60.377 | -48.194 | 85.002 | -4.481 | -0.781 | 7.121 | 13.203 | 0.427 | -2.087 | 2.028 |
Accounts Receivables
| 0.726 | 3.318 | -2.69 | -2.224 | -5 | 0 | 0.152 | 0.61 | -0.153 | -0.514 | 2.028 |
Inventory
| 0 | 0 | 0.211 | -7.179 | 0.782 | 0 | 6.175 | -0.605 | -0.557 | 0.316 | 0 |
Accounts Payables
| 2.834 | 0.092 | -0.219 | -0.057 | -0.6 | -0.516 | -2.327 | 2.686 | 0.667 | -0.09 | 0 |
Other Working Capital
| -3.56 | -63.787 | -45.496 | 94.462 | 0.337 | -0.265 | 9.296 | 9.907 | -0.087 | -1.483 | 0 |
Other Non Cash Items
| 160.701 | -19.114 | 2.131 | 1.747 | 0.402 | 0.449 | 1.332 | 0.471 | 0.115 | 0.193 | 6.602 |
Operating Cash Flow
| -51.161 | -31.631 | -60.382 | 34.881 | -51.435 | -59.161 | -52.037 | -19.683 | -22.463 | -12.686 | -7.661 |
Investing Activities: | |||||||||||
Investments In Property Plant And Equipment
| -0.206 | -1.201 | -1.085 | -0.815 | -0.047 | -0.884 | -0.733 | -0.586 | -1.163 | -0.227 | -0.492 |
Acquisitions Net
| 0 | 13.801 | 2 | 0 | 0 | 0 | -60.154 | -6.898 | 0 | 0 | 0 |
Purchases Of Investments
| 0 | -33.501 | -32.455 | 0 | -18.188 | -15.598 | -61.527 | -28.416 | -3.516 | 0 | 0 |
Sales Maturities Of Investments
| 28.254 | 19.7 | 16.4 | 0 | 18.342 | 41.655 | 60.158 | 6.9 | 0 | 0 | 0 |
Other Investing Activites
| 6.561 | -13.801 | -2 | 0.074 | 0.122 | 0.099 | 0.004 | 0.002 | -3.516 | 0 | 3.003 |
Investing Cash Flow
| 34.609 | -15.002 | -17.14 | -0.741 | 0.229 | 25.272 | -2.098 | -22.1 | -4.679 | -0.227 | 2.511 |
Financing Activities: | |||||||||||
Debt Repayment
| -27.457 | 0 | 0 | -19.313 | -2.8 | 0 | -12.934 | 0 | -2.336 | 0 | 0 |
Common Stock Issued
| 20.25 | 0 | 0 | 12.376 | 107.663 | 0 | 57.114 | 71.613 | 0.109 | 0 | 0 |
Common Stock Repurchased
| 0.231 | 0 | 0 | 0.184 | 0.028 | 0 | 0.18 | 0 | 0 | 0 | 0 |
Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Financing Activities
| -6.169 | 39.215 | 52.897 | 21.368 | 0.178 | 0.697 | 21.843 | -3.954 | 46.133 | 24.771 | 2.983 |
Financing Cash Flow
| -13.145 | 39.215 | 52.897 | 14.431 | 105.041 | 0.697 | 66.023 | 67.659 | 43.906 | 24.771 | 2.983 |
Other Information: | |||||||||||
Effect Of Forex Changes On Cash
| -0.053 | 0.02 | -0.003 | -0.058 | 0.034 | -0.153 | 0.078 | 0.443 | -1.019 | -3.323 | -0.12 |
Net Change In Cash
| -29.75 | -7.398 | -24.628 | 48.513 | 53.869 | -33.345 | 11.966 | 26.319 | 15.745 | 8.535 | -2.287 |
Cash At End Of Period
| 78.288 | 108.038 | 115.436 | 140.064 | 91.551 | 37.682 | 70.622 | 58.656 | 32.337 | 16.592 | 8.057 |